Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.45 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19241863 | 0.88 | HRH3 (0.50) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL28335360 | 0.86 | ALDH1A1 (0.58) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL25682600 | 0.84 | HRH3 (0.51) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL27403191 | 0.82 | HRH3 (0.54) | HRH3HTTSMN1; SMN2NCF1PDE4B | |
| SCHEMBL14320176 | 0.82 | HRH3 (0.50) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL17724130 | 0.80 | HRH3 (0.54) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL24289620 | 0.80 | HRH3 (0.47) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL1552775 | 0.78 | HRH3 (0.61) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL20605142 | 0.78 | HRH3 (0.51) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 | |
| SCHEMBL8257960 | 0.77 | HRH3 (0.54) | HRH3HTTSMN1; SMN2NCF1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203007-A1 | PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | X-CHEM GLOBAL HQ | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203007-A1 | PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | SCN1A, SCN3A, SCN2A | HRH3 379/4885HTT 3750/4885SMN1; SMN2 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.